Chemours
438 hedge funds and large institutions have $2.4B invested in Chemours in 2019 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 119 increasing their positions, 125 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
438
Holders Change
+20
Holders Change %
+4.78%
% of All Funds
8.65%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.14%
New
90
Increased
119
Reduced
125
Closed
59
Calls
$46.5M
Puts
$134M
Net Calls
-$87M
Net Calls Change
-$22.3M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
$35M |
| 2 |
Two Sigma Investments
New York
|
$23M |
| 3 |
Goldman Sachs
New York
|
$38M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$13.1M |
| 5 |
MWA
Marshall Wace Asia
Central,
Hong Kong
|
$46M |
Top Sellers
| 1 |
Norges Bank
Oslo,
Norway
|
$65.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$430M |
| 3 |
JPMorgan Chase & Co
New York
|
$4.16M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
$0 |
| 5 |
SC
Selz Capital
New York
|
$0 |
